 Methadone
"Methadone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)
| Descriptor ID |
D008691
|
| MeSH Number(s) |
D02.522.675
|
| Concept/Terms |
Biodone- Biodone
- Biomet Brand of Methadone Hydrochloride
Dolophine- Dolophine
- Roxane Brand of Methadone Hydrochloride
Metadol- Metadol
- Pharmascience Brand of Methadone Hydrochloride
Metasedin- Metasedin
- Esteve Brand of Methadone Hydrochloride
Symoron- Symoron
- Yamanouchi Brand of Methadone Hydrochloride
Methadose- Methadose
- Rosemont Brand of Methadone Hydrochloride
- Mallinckrodt Brand of Methadone Hydrochloride
Methex- Methex
- Generics Brand of Methadone Hydrochloride
Physeptone- Physeptone
- Martindale Brand of Methadone Hydrochloride
- Phymet
- GlaxoSmithKline Brand of Methadone Hydrochloride
Pinadone- Pinadone
- Pinewood Brand of Methadone Hydrochloride
Methaddict- Methaddict
- addiCare Brand of Methadone Hydrochloride
|
Below are MeSH descriptors whose meaning is more general than "Methadone".
Below are MeSH descriptors whose meaning is more specific than "Methadone".
This graph shows the total number of publications written about "Methadone" by people in UAMS Profiles by year, and whether "Methadone" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2023 | 0 | 2 | 2 | | 2022 | 0 | 2 | 2 | | 2020 | 1 | 1 | 2 | | 2019 | 0 | 1 | 1 | | 2018 | 1 | 1 | 2 | | 2015 | 1 | 1 | 2 | | 2014 | 3 | 1 | 4 | | 2013 | 5 | 1 | 6 | | 2012 | 1 | 0 | 1 | | 2011 | 2 | 0 | 2 | | 2010 | 5 | 2 | 7 | | 2009 | 4 | 0 | 4 | | 2008 | 3 | 1 | 4 | | 2007 | 3 | 1 | 4 | | 2006 | 4 | 2 | 6 | | 2005 | 3 | 2 | 5 | | 2004 | 4 | 1 | 5 | | 2003 | 2 | 0 | 2 | | 2002 | 5 | 2 | 7 | | 2001 | 4 | 2 | 6 | | 2000 | 2 | 1 | 3 | | 1999 | 6 | 0 | 6 | | 1998 | 1 | 0 | 1 | | 1997 | 2 | 0 | 2 | | 1996 | 2 | 2 | 4 | | 1995 | 2 | 1 | 3 | | 1994 | 4 | 1 | 5 | | 1993 | 4 | 0 | 4 | | 1992 | 1 | 0 | 1 | | 1991 | 4 | 1 | 5 | | 1989 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Methadone" by people in Profiles over the past ten years.
-
Czynski A, Laptook A, Das A, Smith B, Simon A, Greenberg R, Annett R, Lee J, Snowden J, Pedroza C, Lester B, Eggleston B, Bremer D, McGowan E. Pragmatic, randomized, blinded trial to shorten pharmacologic treatment of newborns with neonatal opioid withdrawal syndrome (NOWS). Trials. 2023 Jul 21; 24(1):466.
-
Tsai PF, Oliveto AH, Landes RD, Mancino MJ. Characteristics of patients undergoing medication-assisted -treatment for opioid use disorder and their interest in Tai Chi practice. J Opioid Manag. 2023 Jul-Aug; 19(4):329-341.
-
Ware OD, Sweeney MM, Cunningham C, Umbricht A, Stitzer M, Dunn KE. Bupropion Slow Release vs Placebo With Adaptive Incentives for Cocaine Use Disorder in Persons Receiving Methadone for Opioid Use Disorder: A Randomized Clinical Trial. JAMA Netw Open. 2023 03 01; 6(3):e232278.
-
Jones CM, Shoff C, Hodges K, Blanco C, Losby JL, Ling SM, Compton WM. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic. JAMA Psychiatry. 2022 10 01; 79(10):981-992.
-
Rezaeiahari M, Fairman BJ. Impact of COVID-19 on the characteristics of opioid overdose deaths in Arkansas. Int J Drug Policy. 2022 11; 109:103836.
-
Pro G, Utter J, Haberstroh S, Baldwin JA. Dual mental health diagnoses predict the receipt of medication-assisted opioid treatment: Associations moderated by state Medicaid expansion status, race/ethnicity and gender, and year. Drug Alcohol Depend. 2020 04 01; 209:107952.
-
Pro G, Zaller N. Interaction effects in the association between methadone maintenance therapy and experiences of racial discrimination in U.S. healthcare settings. PLoS One. 2020; 15(2):e0228755.
-
Kroska EB, Meller EW, Doyle R, Coker JL, Knight BT, Ray-Griffith SL, Nembhard WN, Stowe ZN. Drug screening during pregnancy: Urine dip cups measure up. Drug Alcohol Depend. 2019 11 01; 204:107461.
-
Coker JL, Catlin D, Ray-Griffith S, Knight B, Stowe ZN. Buprenorphine medication-assisted treatment during pregnancy: An exploratory factor analysis associated with adherence. Drug Alcohol Depend. 2018 11 01; 192:146-149.
-
Brinkley-Rubinstein L, McKenzie M, Macmadu A, Larney S, Zaller N, Dauria E, Rich J. A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release. Drug Alcohol Depend. 2018 03 01; 184:57-63.
-
Timko C, Schultz NR, Cucciare MA, Vittorio L, Garrison-Diehn C. Retention in medication-assisted treatment for opiate dependence: A systematic review. J Addict Dis. 2016; 35(1):22-35.
-
Rich JD, McKenzie M, Larney S, Wong JB, Tran L, Clarke J, Noska A, Reddy M, Zaller N. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial. Lancet. 2015 Jul 25; 386(9991):350-9.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|